Video Experimental Relacionado

Updated: Jan 8, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
06:51

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

15.8K

Células T CAR anti-CD38 alogénicas y multiplex editadas por bases para inmunoterapia "listas para usar"

Roland Preece1, Oliver Gough1, Akshay Joshi1

  • 1UCL Great Ormond Street Institute of Child Health, WC1N 1EH, London.

Haematologica
|December 24, 2025
PubMed
Resumen

La edición de bases crea células T CAR38 universales dirigidas a cánceres CD38+.

Palabras clave:
inmunoterapiaedición de genesneoplasias hematológicascélulas T CARCD38terapia alogénicaedición de basesrechazo inmunitariofratricidioneoplasias hematológicas

Más Videos Relacionados

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.4K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.2K

Videos de Conceptos Relacionados

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K